Improved long-term prognostic value of coronary CT angiography-derived plaque measures and clinical parameters on

Christian Tesche1,2,3,4, Maximilian J Bauer5,6, Moritz Baquet7

  • 1Department of Cardiology and Intensive Care Medicine, Heart Center Munich-Bogenhausen, Munich, Germany. tesche.christian@gmail.com.

European Radiology
|July 30, 2020
PubMed

Insights

Machine learning (ML) models significantly improve the prediction of major adverse cardiac events (MACE) by integrating coronary CT angiography (cCTA) plaque data and clinical factors. This ML approach offers superior risk stratification compared to traditional methods.

Area of Science:

  • Cardiovascular Imaging
  • Artificial Intelligence in Medicine
  • Predictive Analytics

Background:

  • Coronary artery disease (CAD) risk stratification relies on various clinical and imaging parameters.
  • Current methods for predicting major adverse cardiac events (MACE) have limitations in accuracy and integration of complex data.
  • Coronary CT angiography (cCTA) provides detailed plaque information that could enhance risk prediction.

Purpose of the Study:

  • To assess the long-term prognostic capability of machine learning (ML) models in predicting MACE.
  • To compare the performance of ML models against conventional risk scores and plaque measures derived from cCTA.
  • To evaluate the utility of ML in integrating diverse patient data for improved cardiac risk stratification.

Main Methods:

  • Retrospective analysis of 361 patients with suspected CAD who underwent cCTA.
  • Utilized a boosted ensemble algorithm (RUSBoost) with decision trees for MACE prediction.
  • Input data included cCTA-derived adverse plaque features, CT risk scores, and clinical cardiovascular risk factors.
  • Model performance was evaluated using the area under the curve (AUC) with repeated nested cross-validation.

Main Results:

  • The ML model demonstrated a significantly higher discriminatory power for MACE prediction (AUC 0.96) compared to conventional CT risk scores (AUCs 0.84-0.89), adverse plaque measures (AUCs 0.72-0.82), and clinical parameters (AUCs 0.71-0.76).
  • The ML model also outperformed logistic regression analysis (AUC 0.96 vs. 0.92).
  • MACE occurred in 8.6% of patients over a median follow-up of 5.4 years.

Conclusions:

  • Integrating ML models with cCTA data and clinical information substantially improves long-term MACE prediction.
  • ML algorithms offer a powerful tool for enhancing patient risk stratification in suspected CAD.
  • ML-based risk stratification shows superior diagnostic performance over traditional methods alone.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
262
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
171
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
123
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
163
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
748
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
513